A Groundbreaking Forum at HIMSS25 Focused on Behavioral Health
LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- Informa Connect announces a landmark collaboration with Behavioral Health Tech to present the...
Autism
Stride Autism Centers Named a Winner of the 2025 Top Workplaces Award in the Great Plains
Stride Autism Centers Named a Winner of the 2025 Top Workplaces Award in the Great Plains Stride Autism Centers, a...
Behavioral Innovations Celebrates 25 Years of Transforming Lives Through Compassionate ABA Therapy
Honoring a Quarter Century of Dedicated Support for Children with Autism and Their Families DALLAS, TEXAS / ACCESSWIRE / January...
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
BOSTON, MA / ACCESSWIRE / January 14, 2025 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing...
Clinical Trial of NeuroSigma’s Monarch eTNS System for ADHD at King’s College London Completes Enrollment
ATTENS (ADHD trial of external trigeminal nerve stimulation) Project, led by Professor Katya Rubia at the Institute of Psychiatry, Psychology...
RethinkFirst Appoints Ben Semmes as Chief Executive Officer
Transformational executive to lead company through the next phase of growth and innovation NEW YORK, Jan. 8, 2025 /PRNewswire/ --...
Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
Vancouver, Canada, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
GARDEN CITY, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a...
SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder
TEL AVIV, Israel, Dec. 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), announced that AutoMax Motors...
New Two-Part Blog Series Offers Holiday Tips for Children with Special Needs
CHICAGO, Dec. 16, 2024 /PRNewswire/ -- Westside Children's Therapy, a leading provider of pediatric therapy services, is thrilled to announce...
Action Behavior Centers and Non-Profit 29 Acres Announce Community Partnership to Empower Adults with Autism
AUSTIN, TX / ACCESSWIRE / December 11, 2024 / Action Behavior Centers (ABC), a provider of Applied Behavior Analysis (ABA)...
New Clinical Trial of eTNS for Pediatric ADHD to Commence at Denmark’s Center for Evidence-Based Psychiatry
LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for...
Mentavi Health Adds Sleep Coach Amanda Chocko to Support Its Comprehensive Mental Health Services
Recognizing the connection between sleep disorders and conditions like ADHD, the leader in online mental health testing, diagnosis and care...
Mentavi Health Adds Sleep Coach Amanda Chocko to Support Its Comprehensive Mental Health Services
Recognizing the connection between sleep disorders and conditions like ADHD, the leader in online mental health testing, diagnosis and care...
MGI Tech announces partnership with Universidad de San Martín de Porres to strengthen human genetics research
The implementation of MGI Tech's next-generation genomic sequencing (NGS) technologies will strengthen scientific research in the country, enabling the identification...
Catalight Partners with Nabla to Reduce Practitioner Documentation Burden and Elevate Autism and I/DD Care
After a successful 6-week pilot program, Nabla's ambient AI assistant is rolling out to Catalight's clinical team of case managers,...
Orion Research Foundation grants EUR 1,109,000 for research in 2025
Orion Research Foundation grants EUR 1,109,000 for research in 2025 Press release 22 November, 2024 at 9.00 EET Orion Research...
Head：China makes collaborative efforts in healing people with mental disorders with AI
BEIJING, Nov. 20, 2024 /PRNewswire/ -- After a long day at work, Ni Beiyue sits in front of his computer at home,...
Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem
Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,...